Prospective, Randomized, Fellow Eye-Controlled Study of Postoperative Pain and Inflammation Control with an Intracanalicular Dexamethasone 0.4 mg Ophthalmic Insert Following Small Incision Lenticule Extraction.
Kathleen J JeeJoseph LingShamik BafnaThomas ChesterJeffrey AugustineWilliam F WileyPublished in: Clinical ophthalmology (Auckland, N.Z.) (2022)
The DEX insert was preferred by more patients and controlled postoperative inflammation and pain comparably to topical PRED in eyes undergoing SMILE. There were no statistically significant differences in visual outcomes between the two groups.
Keyphrases
- postoperative pain
- oxidative stress
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- chronic pain
- peritoneal dialysis
- double blind
- patients undergoing
- low dose
- optical coherence tomography
- clinical trial
- prognostic factors
- high dose
- randomized controlled trial
- adipose tissue
- skeletal muscle
- phase iii
- patient reported